Certain foods create disproportionate problems on GLP-1 therapy because of how these medications change your digestive system
As the authors note, the emergence of therapies with diverse mechanisms, including dual GCG/GLP-1 receptor agonism, may help enable more individualized approaches to cardiometabolic disease management
Zhu H, Tian P, Qian X, Gu L, Zhao J, Wang G, et al
Tirzepatide activates two pathways
For example, you might use the left side of your stomach one week and the right side the next
It turns out healthcare providers nationwide are administering an unregulated, potentially dangerous product claimed to contain 'compounded semaglutide.' It's crucial to note that I offer FDA-approved semaglutide products as a healthcare provider, yet my primary concern is patient safety and upholding the medical profession's integrity, not competition